PainReform (PRFX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
PainReform Ltd. has appointed Eyal Broder as the Interim Chief Financial Officer, succeeding Dr. Ehud Geller, who remains the Executive Chairman and Interim CEO. The company regained compliance with Nasdaq’s minimum bid price requirement after a period of non-compliance. These changes could influence investor confidence as PainReform navigates its financial and operational strategies.
For further insights into PRFX stock, check out TipRanks’ Stock Analysis page.
